We report here a recurrent frameshift mutation within the carboxyl-terminal noncollagenous domain coding region of the type X collagen gene (COLIOA1) in a Japanese patient with Schmid metaphyseal chondrodysplasia. The mutation involves deletion of a CT dinucleotide from position 1992 (1992deiCT), and produces a frameshift which creates a premature termination codon close to the site of the deletion. The predicted length of the mutant polypeptide is 664 amino acids, which is shorter than the wild type polypeptide (680 amino acids). A 1992delCT mutation of COLIOA1 has been previously reported in one family. The independent occurrence of de novo mutation of this specific dinucleotide repeat suggests that this region is a possible mutational hot spot on COLIOA1.
Schmid metaphyseal chondrodysplasia (SMCD) is an autosomal dominant disorder characterized by mild dwarfism and coxa vara. Seventeen different SMCD mutations reported to date have all been located within the carboxyl (C)-terminal noncollagenous domain coding region of the type X collagen gene (COLIOA1) (Warman et al., 1993; Wallis et al., 1994; McIntosh et al., 1994 McIntosh et al., , 1995 DharmavarReceived March 21, 1996; Revised version accepted June 17, 1996 . * To whom correspondence should be addressed. am et al., 1994; Chan et al., 1995; Bonaventure et al., 1995) . It has been suggested that mutations of this domain prevent the mutant polypeptides from participation in stable triple-helix formation and lead to a reduction in the amount of normal protein. Alternatively, the presence of abnormal type X homotrimers may interfere with the formation of large multimeric aggregates. We report here a recurrent frameshift mutation within the C-terminal noncollagenous domain coding region of COLIOA1 in a Japanese patient with SMCD.
A 3-year-old Japanese girl was diagnosed as having SMCD on the basis of clinical features and radiographic data at the Osaka Medical Center and Research Institute for Maternal and Child Health. Her parents were clinically normal and were unrelated. DNA was extracted from peripheral blood leukocytes by a standard method (Sambrook et al., 1989) . Since all SMCD mutations reported to date have been located within the C-terminal noncollagenous domain of COL 10A1, we used two sets of polymerase chain reaction (PCR) primers to study the portion of the genomic DNA that included a sequence encoding this entire C-terminal domain. The sequences of the primers used (primer H15: 5'-TCAATGGACCCA-CCGGGC-3', primer H!8: 5'-TGATGGCACTCCCTGAAGCCTG-Y, primer H17: 5'-GCCTGTGTCTGCTTTTACTG-Y, and primer H23: 5'-TTCAGCCTA-CCTCCATATGC-3') were identical to those reported previously (McIntosh et al., 1994) . Primers H15 and H18 amplified a 471-bp product, while primers H17 and H23 amplified a 490-bp product. Amplification was performed with 0.5 U of TaKaRa Taq (Takara, Shiga, Japan) in the following reaction mixture with a total volume of 25 ,ul: 50 mM KC1, 1.5 mM MgC12, 10 mM Tris-HC1 (pH 8.3), 100 elM of each dNTP, 100 ng DNA, and 12.5 pmol of each primer. Thirty cycles of 30 sec each at 94~ 62~ and 72~ were used. The PCR products were identified on 3% low melting point agarose gel and subjected to heteroduplex analysis using MDE TM gel (AT Biochem, Malvern, PA) according to the manufacturer's instructions. In addition, the amplified products were purified with a QIAEX II gel extraction kit (Qiagen, Chatsworth, CA) and directly sequenced using a Taq Dye Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA) and an Applied Biosystems 373A DNA sequencer.
MDE TM gel electrophoresis of the PCR products amplified with primers H17 and H23 indicated the presence of heteroduplex bands in the proband, but not in her parents (Fig. 1) . Direct DNA sequencing of the PCR product suggested that the patient was heterozygous for the deletion of a CT dinucleotide from position 1992 (1992delCT) (data not shown). In order to confirm this mutation, the PCR product of primers H17 and H23 from the patient was digested with HindIII/NsiI and was subcloned into the HindIII/PstI cloning sites of pBluescript II SK + (Stratagene, La Jolla, CA). The presence of 1992delCT mutation was confirmed by sequencing of DNA from individual subclones (Fig. 2) . This frameshift mutation created a premature termination codon close to the site of the deletion. The predicted length of the mutant polypeptide is 664 amino acids, which is shorter than the wild type polypeptide (680 amino acids). Neither of the parents had this mutation. A previously reported polymorphic amino acid substitution (Gly545Arg) (Sweetman et aL, 1992) was detected in the patient and her father, but not in her mother (data not shown).
All of the known SMCD mutations are different (Warman et al., 1993; Wallis et aZ, 1994; McIntosh et aZ, 1994 McIntosh et aZ, , 1995 Dharmavaram et aL, 1994; Chan et aL, 1995; Bonaventure et aL, 1995) . However, three of the reported deletions were initiated at nucleotide 1856 of C O L I O A 1 . Thus, it seems that this nucleotide may Vol. 41, No. 3, 1996 be more prone to mutational events. A 1992delCT mutation of COLIOA 1 has been previously reported in one family (McIntosh et al., 1994) . The data presented here indicate that an apparently unrelated Japanese SMCD patient has a recurrent 1992delCT mutation of COLIOA1. This dinucleotide locates within the direct repeat sequence (CTCT at nt 1992 (CTCT at nt -1995 , and the gene deletions have been suggested to occur preferentially at such sites (Krawczak and Cooper, 1991) . The independent occurrence of de novo mutation in this specific dinucleotide repeat suggests that this region is a possible mutational hot spot on COLIOA1. Although some SMCD patients are reported to have no mutation of COLIOA1 (Bonaventure et al., 1995) , these observations indicate allelic heterogeneity and confirm the role of mutation within the C-terminal noncollagenous domain coding region of COLIOA1 in the pathogenesis of most SMCD.
